Cargando…

Molecular insights into Parkinson's disease

Parkinson’s disease is a neurodegenerative movement disorder characterized by loss of midbrain dopaminergic neurons leading to motor abnormalities and autonomic dysfunctions. Despite intensive research, the etiology of Parkinson’s disease remains poorly understood leaving us with no effective therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Bobby, Beal, M. Flint
Formato: Texto
Lenguaje:English
Publicado: Faculty of 1000 Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096887/
https://www.ncbi.nlm.nih.gov/pubmed/21655332
http://dx.doi.org/10.3410/M3-7
_version_ 1782203757563478016
author Thomas, Bobby
Beal, M. Flint
author_facet Thomas, Bobby
Beal, M. Flint
author_sort Thomas, Bobby
collection PubMed
description Parkinson’s disease is a neurodegenerative movement disorder characterized by loss of midbrain dopaminergic neurons leading to motor abnormalities and autonomic dysfunctions. Despite intensive research, the etiology of Parkinson’s disease remains poorly understood leaving us with no effective therapeutic options. However, the recent identification of genes linked to heritable forms of Parkinson’s disease has revolutionized research in the field and has begun to provide new clues to disease pathogenesis. Here we discuss these recent genetic advances and highlight their significance in our quest to better understand common underlying disease mechanisms that will help us identify innovative neuroprotective therapies for Parkinson’s disease.
format Text
id pubmed-3096887
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Faculty of 1000 Ltd
record_format MEDLINE/PubMed
spelling pubmed-30968872011-06-08 Molecular insights into Parkinson's disease Thomas, Bobby Beal, M. Flint F1000 Med Rep Review Article Parkinson’s disease is a neurodegenerative movement disorder characterized by loss of midbrain dopaminergic neurons leading to motor abnormalities and autonomic dysfunctions. Despite intensive research, the etiology of Parkinson’s disease remains poorly understood leaving us with no effective therapeutic options. However, the recent identification of genes linked to heritable forms of Parkinson’s disease has revolutionized research in the field and has begun to provide new clues to disease pathogenesis. Here we discuss these recent genetic advances and highlight their significance in our quest to better understand common underlying disease mechanisms that will help us identify innovative neuroprotective therapies for Parkinson’s disease. Faculty of 1000 Ltd 2011-04-01 /pmc/articles/PMC3096887/ /pubmed/21655332 http://dx.doi.org/10.3410/M3-7 Text en © 2011 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Thomas, Bobby
Beal, M. Flint
Molecular insights into Parkinson's disease
title Molecular insights into Parkinson's disease
title_full Molecular insights into Parkinson's disease
title_fullStr Molecular insights into Parkinson's disease
title_full_unstemmed Molecular insights into Parkinson's disease
title_short Molecular insights into Parkinson's disease
title_sort molecular insights into parkinson's disease
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096887/
https://www.ncbi.nlm.nih.gov/pubmed/21655332
http://dx.doi.org/10.3410/M3-7
work_keys_str_mv AT thomasbobby molecularinsightsintoparkinsonsdisease
AT bealmflint molecularinsightsintoparkinsonsdisease